Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
65 Cards in this Set
- Front
- Back
This organization defines pain as, " An upleasent sensory & emotional experience associated w/ actual or potential tissue damage, or described in terms of such damage.
|
IASP
|
|
One of the 5-dimensions of pain that involves the transmission of the nociceptive stimuli of pain
|
Physiogical
|
|
One of the 5-dimensions of pain that involves the actual location intensity.
|
Sensory
|
|
One of the 5-dimensions of pain that involves that actual suffering emotion.
|
Affective
|
|
One of the 5-dimensions of pain that involves the persons reaction to pain along with how the react to it.
|
Behavioral
|
|
One of the 5-dimensions of pain that involves the person's attitudes, beliefs, eval, & goals towards pain.
|
Cognition
|
|
Inflammation & the subsequent release of chemical mediatiors increases the likelihood of transduction. This increased susceptibility is called...
|
Sensitization
|
|
A chemical in the distant terminals of the PAN that will sensitize it & dialate nearby blood vessels, w/ subsequent production of edema & release of histamine from mast cells.
|
Substance P
|
|
Neurons that project from the periphery to the spinal cord are also refered to as this.
|
First order neurons
|
|
Large fibers that are enclosed within the myelin sheaths, allowing them to conduct impulses at a rapid rate.
|
A-Fibers
|
|
The smallest fibers that are unmyelinated, which conduct at the slowest rate.
|
C-Fibers.
|
|
Part of nociceptive pain, characterized as aching or throbbing that is well localized, arises from bone, joint, muscle, skin or connective tissue.
|
Somatic Pain
|
|
Part of neuro-pathic pain that can be centrally or peripherally generated
|
Deafferentation
|
|
Part of nociceptive pain, which can result from stimuli such as a tumor involvement, or obstruction, arises from interal organs such as bladder or intestine.
|
Viceral Pain
|
|
Pain that has sudden onset w/ a duration of <3months. Severity is mild to severe, whereas the cause can generally be indentified.TX includes analgesics for symptom control & underlying causes. Diminishes over time.
|
Acute Pain
|
|
Part of the pain assessment that includes the onset & duration.
|
Pattern
|
|
Pain that persists for longer periods, often defined as longer than 3 months, which usually waxes & wains over time.
|
Chronic
|
|
Examples of this kind of pain include dressing changes, position changes, movement, eating & catherization. Fast acting drugs are used to treat this sort of pain.
|
Breakthough Pain
|
|
Part of the pain assessment that includes the location of pain that assists in identifying the possible causes of pain & determining it's tx.
|
Area
|
|
The increased response to "NOXIOUS" stimuli (i.e. not sensitization)
|
HYPER-algeisa
|
|
Painful responsed to normally innoucuous sitmuli.
|
Allodynia
|
|
Prolonged pain after the original noxious stimulus ends
|
Persistent Pain
|
|
The spead of pain to uninjured tissue.
|
Referred Pain
|
|
Part of the pain assessement that determines the severity of pain, which provides a reliable measurement used in detertmining the type of tx, as well as the evaluation of tx effectiveness.
|
Intensity
|
|
Part of the pain assessement that refers to the quality or char. of pain. This insturment captures the Qual-itative & affective components of pain.
|
Nature
|
|
Pain that can be described as sharp, arching, throbbing & cramping. (i.e. is it Neurceptive or Nociceptive)
|
Nociceptive Pain
|
|
Basic Principle of the pain tx where the patient must always be believed.
|
Frist Principle
|
|
Basic Principle of the pain tx
where every patient deserves adequate pain management established by JACHO |
Second Principle
|
|
Basic Principle of the pain tx
where tx itself must be based on the patient's goals. |
Third Principle
|
|
Basic Principle of the pain tx
where tx plans should be combined with drugs & non-drug therapies. |
Fourth Principle
|
|
Basic Principle of the pain tx where a multi-disciplinary approach is necessary to address all dimensions of pain.
|
Fifth Principle
|
|
Basic Principle of the pain tx
where all therapies must be evaluated to ensure that they are meeting patient's goals. |
Sixth Component
|
|
This type of teaching should be the cornerstone to the tx plan, involving these two groups of people.
|
Patient & Family
|
|
A type of dosage that are provide for opioids & are important because there is no upper limit.
|
Equianalgesic Dose
|
|
Analgesic scheduling should focus on this in conjuction to ongoing control of pain, rather than providing analgesics only after the patient's pain become severe.
|
Prevention
|
|
When pain is around 1-3
non-opioids(e.g asprin) NSAIDS & aceteminophen are used. This is used for what intensity of pain. |
Mild Pain: Step 1 Drugs
|
|
When pain is of this intesity, from 4-6, but persistant despite non-opioid therapy this step of drugs are used in the form of opioids. (e.g. Codeine, Oxycodone)
|
Mild/Moderate: Step 2 Drugs
|
|
Morphine is an example of this, which binds to the receptor & causes analgesia.
|
Opioid Agonist
|
|
Narcan is an example of this, where it binds to the receptor; but blocks other effects of opioid receptor activation, such as respiration depression & sedation. Doesn't produce analgesia.
|
Opioid Antagonist
|
|
Binds weakly on the mu & kappa receptors which decrease their analgesic efficacy. Currently have limited availability & low clinical value.
|
Partial Opioid Aganoist
|
|
When pain intensity is between 7-10, this step level of drugs are used because they are potent & have no analgesic ceiling. (eg. Morphine, hydromorphine, methadone).
|
Step 3 Mu Angonist
|
|
This drug is the standard of comparison for all other opioid drugs.
|
Morphine
|
|
Side effects for this step level drug include constipation, nausea, vomiting, sedation, respiratory depression & pruritus. (Repeat Question)
|
Step 3
|
|
The most common opioid side effect.
|
Constipation
|
|
This symptom is often a side effect in opioid naive patients. Can be relieved by Reglan.
|
Nausea
|
|
Drugs used in conjuntion w/ opioids & non-opioids. Sometimes referred to as CO-Analgesics. 1)They can enhance opioids & nonopioids, 2)possess own analgesic properties, 3)counteracts side effects of other analgesics.
|
Adjuvant Analgesics
|
|
Generally the administration route of choice for persons with a functioning GI.
|
Oral
|
|
For this route pain relief typically occurs w/in 5-7 minutes after administration
|
Sublingual/Buccal
|
|
Aduvant drugs that enhance the descending inhibitory syst. by preventing cellular reuptake of Nor-epinepherin & serotinin. Resultin higher levels inhibit nociceptive signals in CNS
|
Antidepressants
|
|
Adjuvant drugs which fall in the same class as gabapentin, tegretol & clonazepam, stablize the membrane of the neuron & prevent NEURO-pathic pain transmission. Prophylactic for headaches.
|
Anti-Seizure Agents
|
|
Common side effects of this type of adrenergic agonists are orothstatic hypotension, sedation & dry mouth.
|
Alpha 2
|
|
Aduvant drug that decrease edema & inflammation, & sometimes tumors. Side effects include GI bleeding, impaired healing fluid retention, muscle wasting, osteoporis & susceptibility to infection.
|
Corticosteroid
|
|
Adjuvant drugs which is an anesthetic used to interrupt neuropathic pain signals to the brain. Side effects include paresthisas & seizures in high doses. Also can effect cardiac conductivity causing arrhythmias & myocardial depression. (i.e. what kind of anesthetic)
|
Local Anesthetic
|
|
A common non-drug therapy for pain thought to provide relief by activating mechanoreceptors in the muscles
|
Vibration
|
|
Involves the delivery of an electric current through electrodes applied to the skin surface over the painful region, at trigger point, or over a peripheral nerve.
|
TENS Unit
|
|
Stimulates deeper peripheral tissues through the insertion of a needle to which a stimulator is attached near a large peripheral or spinal nerve.
|
PENS Unit
|
|
Through this type of management, the nurse acts as planner, educator, patient advocate, interpreter & supporter of patient & family.
|
Collaborative
|
|
Barrier to Effective Pain Management that occurs with chronic exposure to drugs, char. by the need for increased opioid do to maintain same degree of analgesia.
|
Tolerence
|
|
Barrier to Effective Pain Management manifested by a withdrawl syndrome that occurs when blood levels of the drug are abruptly decreased.
|
Physical Dependence
|
|
Barrier to Effective Pain Management which involves a complex neurobiological condition char. by a drive to obtain & take substances for other than their prescribed therapeutic value.
|
Addiction
|
|
The issue involving medical & nursing curricula having spent little time teaching about pain & symptom management or providing adequate skills.
|
Education
|
|
This rule states that if an unwanted consequence (i.e. hastened death) occurs as a result of an action taken to achieve a moral good (i.e. pain relief), then the action is justified.
|
Rule of Double Effect
|
|
A common problem in the elderly & is often associated w/significant physical & psych disability.
|
Chronic Non-Malignant Pain
|
|
Often results in depression, sleep disturbances, decrease mobility, increased hospitaliztion & social role dysfuntion.
|
Chronic Pain
|
|
The use of this drug class is associated w/high frequency of serious GI bleeding.
|
NSAIDS
|